Gossamer Bio (GOSS) Earnings
Gossamer Bio reported on November 4, 2026: EPS of -16.80 against -5.55 expected, a miss.
Summary
In the quarter ended June 2026, Gossamer Bio had revenue of $9M, down 19.6% on a year earlier, and diluted EPS of -0.08.
The next report is expected on Wednesday, November 11, 2026, with EPS expected around -5.55.
Report dates
| Report | Date | Time | EPS estimate | EPS reported | Result |
|---|---|---|---|---|---|
| Next | Wed Nov 11, 2026 | — | -5.55 | — | — |
| Last | Wed Nov 4, 2026 | — | -5.55 | -16.80 | Missed |
Dates from company announcements and exchange calendars; estimates are the consensus where available. See the full earnings calendar.
Also reporting the week of November 2
| Company | Date | Time |
|---|---|---|
| Apple Inc AAPL | Mon Nov 2 | Reported |
| Advanced Micro Devices Inc AMD | Tue Nov 3 | Reported |
| Palantir Technologies Inc. PLTR | Mon Nov 2 | Reported |
| Toyota Motor Corporation ADR TM | Wed Nov 4 | Reported |
| Amgen Inc AMGN | Tue Nov 3 | Reported |
| Arista Networks ANET | Tue Nov 3 | Reported |
| McDonald’s Corporation MCD | Wed Nov 4 | Reported |
| Shopify Inc SHOP | Tue Nov 3 | Reported |
Quarterly results
The last 12 quarters from Gossamer Bio's 10-Q and 10-K filings with the SEC. Growth is against the same quarter a year earlier. EPS here is GAAP diluted EPS as filed; the reported EPS compared with estimates above can be on the company's adjusted basis, so the two can differ.
| Quarter ended | Revenue | Growth | EPS (diluted) | Growth | Op. margin | Filed |
|---|---|---|---|---|---|---|
| Jun 30, 2026 | $9M | -19.6% | -0.08 | — | -282.2% | 2026-08-13 |
| Mar 31, 2026 | $17M | +71.5% | -0.20 | — | -264.6% | 2026-05-15 |
| Dec 31, 2025 | $14M | +47.1% | — | — | -333.6% | 2026-03-17 |
| Sep 30, 2025 | $13M | +40.2% | -0.21 | — | -369.4% | 2025-11-05 |
| Jun 30, 2025 | $11M | -88.0% | -0.17 | — | -337.4% | 2025-08-05 |
| Mar 31, 2025 | $10M | — | -0.16 | — | -372.2% | 2025-05-15 |
| Dec 31, 2024 | $9M | — | — | — | -385.2% | 2025-03-13 |
| Sep 30, 2024 | $9M | — | -0.14 | — | -357.8% | 2024-11-07 |
| Jun 30, 2024 | $96M | — | 0.22 | — | 54.3% | 2024-08-12 |
| Mar 31, 2024 | $0 | — | -0.19 | — | — | 2024-05-07 |
| Dec 31, 2023 | $0 | — | — | — | — | 2024-03-05 |
| Sep 30, 2023 | $0 | — | -0.21 | — | — | 2023-11-09 |
Questions about Gossamer Bio
When does Gossamer Bio report earnings?
Gossamer Bio's next earnings report is expected on November 11, 2026.
Did Gossamer Bio beat earnings estimates?
In its report on November 4, 2026, Gossamer Bio missed the EPS estimate: -16.80 reported against -5.55 expected.
How did Gossamer Bio do last quarter?
In the quarter ended June 2026, Gossamer Bio had revenue of $9M, down 19.6% on a year earlier, and diluted EPS of -0.08.
From Gossamer Bio's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.